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Objective: To assess the efﬁcacy of triclabendazole (TCBZ) in porcine cysticercosis.
Methods: Eighteen naturally infected cysticercosis pigs were divided into 3 groups of 6
individuals each. The ﬁrst group was treated orally with TCBZ at a single dose of 30 mg/
kg of body weight, the second group was treated orally with oxfendazole at a single dose
of 30 mg/kg of body weight and the third group received a placebo (control group). All
animals were kept under the same management conditions. The pigs were euthanized
17 wk post-treatment and the number of surviving cysts in muscles was assessed and
compared between groups.
Results: All pigs treated with oxfendazole had only degenerated cysts in their carcasses.
In contrast, TCBZ had very little effect against the parasitic cysts. Cysts from pigs in the
TCBZ group looked apparently normal after treatment. However, histological evaluation
showed a mild to moderate degree of inﬂammation.
Conclusions: TCBZ is not an efﬁcacious drug against Taenia solium cysticercosis in
swine using a single dose.1. Introduction
The disease complex, taeniasis/cysticercosis caused by the
pork tapeworm Taenia solium (T. solium), is a very important
zoonotic disease in developing countries [1,2]. The adult
T. solium tapeworm localizes in the small intestine of humans,
the deﬁnitive host. The eggs of T. solium are eliminated into
gravid proglottids with the faeces, and then they are ingested
by pigs, the intermediate host. The T. solium metacestode then
develops in different organs of the pig, principally muscles
[3,4]. However, humans can act as accidental hosts when they
ingest eggs in contaminated food [3,5].
During the last decade, a variety of strategies have been
performed for the control of T. solium cysticercosis including
animal inspection, massive chemotherapy for T. solium in
humans and pigs from endemics areas, health education, and pig
vaccination [2,6–9]. For this purpose, many studies have beenperformed to evaluate the efﬁcacy of different drugs against
porcine cysticercosis [10]. Of these drugs, albendazole and
oxfendazole (OFZ), members of the benzimidazole drugs, are
efﬁcacious for the treatment of the porcine cysticercosis [11].
Albendazole has been used in humans since 1979, and
currently it is considered the drug of preference in humans for
its availability, low cost and efﬁcacy [5,11]. Albendazole does
not seem to be a good option for ﬁeld interventions due to the
requirement for multiple doses [10]. OFZ, used in a single oral
dose of 30 mg/kg, is the drug of choice for the treatment of
porcine cysticercosis [12]. The widely used triclabendazole
(TCBZ), another member of the benzimidazole family, is
efﬁcacious against adults and larval stages of a variety of
helminthic parasites [13,14]. The aim of this study was to
compare the efﬁcacy of a single oral dose of TCBZ or OFZ
against T. solium cysticercosis in naturally infected pigs.
2. Materials and methods
2.1. Study design and settings
The study was conducted at the animal facilities of the
Laboratory of Veterinary Epidemiology and Economics, School
of Veterinary Medicine, National University of San Marcos inrticle under the CC BY-NC-ND license (http://
Table 1
Median, range and feature of larval stage of T. solium after treatment of
pigs.
Indexes Group
TCBZ OFZ Control
Animals 6 6 6
Male 2 2 2
Weight (kg)a 77
(67–86)
95
(66–117)
81
(49–119)
Number of
viable cysts
1414
(511–4052)b
0b 1658
(131–2575)b
Number of
degenerated cysts
0 259
(38–1953)
0
aMean and range; bSigniﬁcant difference between control and treatment
(Kruskal–Wallis test, P < 0.01).
Figure 1. Histological section of cysts from a pig treated with TCBZ (H&E
stain).
It showed a signiﬁcant inﬂammatory reaction. Multifocal lymphocytic
myositis (A). Presence of lymphocytes, eosinophils, macrophages, plas-
mocytes, and ﬁbroblasts (B).
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and transported to the animal facilities in Lima. Pigs were ran-
domized in three similar groups (TCBZ, OFZ, and placebo)
using a random numbers table. All pigs were coded and labelled
with ear tags.
2.2. Animals
Eighteen adult pigs were acquired in Huancayo, a
cysticercosis-endemic area in the Peruvian highlands [15]. All
animals were positive to cysticercosis by tongue examination,
and conﬁrmed by antibody detection on serum enzyme-linked
immunoelectro transfer blot [16,17]. Only animals with more
than one cyst in the tongue and more than four antigen bands
in enzyme-linked immunoelectro transfer blot were included in
the study. All pigs were vaccinated against hog cholera imme-
diately after purchase.
2.3. Treatment protocol
The pigs were randomly placed in three different groups of
six pigs each. Pigs in group 1 received a single oral dose of
30 mg/kg body weight of TCBZ (Trisan 12%, Montana S.A.,
Peru). Pigs in group 2 were treated orally with OFZ (Syn-
anthic® 9.06%, Fort Dodge, Mexico), using a single dose of
30 mg/kg body weight. Control pigs (group 3) received sugar
water as a placebo. Each treatment group was housed in a
single pen.
2.4. Necropsy
All animals were euthanized 17 wk after treatment, and
necropsied at the School of Veterinary Medicine facilities in
Lima, Peru. Pigs were anesthetized and sacriﬁced by intramus-
cular injection of a combination of ketamine (20 mg/kg) and
xylazine (2 mg/kg) followed by intravenous injection of pento-
barbital sodium overdose (60 mg/kg). Necropsy was performed
immediately after euthanasia, and muscles from arms and legs
were dissected, and all cysts were counted and classiﬁed. Cysts
were classiﬁed as viable if a deﬁned cystic structure with clear
liquid content was still present, and degenerated if this had been
replaced by semi-solid contents or an inﬂammatory scar (calci-
ﬁed nodule).
2.5. Histological analysis
Five randomized cysts from the muscles of each pig
were ﬁxed in 10% formalin, embedded in parafﬁn, then
sectioned at 5 mm and stained with haematoxylin and eosine
(H&E), as well as Von Kossa stain to assess the presence of
calcium.
2.6. Data analysis
Parasitic load was expressed in median with their respective
ranges. A non-parametric one-way analysis of variance (Krus-
kal–Wallis) test was used to estimate the difference in the
number of cysts between treatment groups. Data was analysed
using STATA 10 statistical software (v10.0; StataCorp LP,
College Station, TX). Differences were considered statistically
signiﬁcant at P-value <0.05.2.7. Ethical approval
The study was approved by the Animal Ethics Committee of
the School of Veterinary Medicine, National University of San
Marcos, Lima, Peru.
3. Results
During treatment and follow up, pigs from the treated groups
involved in this experiment were apparently normal without
apparent adverse events. All pigs used in this study were posi-
tive to cysticercosis at tongue examination as well as positive to
4 or more antibody bands enzyme-linked immunoelectro transfer
blot. After necropsy, the overall parasite load including viable or
degenerated cysts for each group was 1658 (131–2575) (me-
dian, interquartile range) cysts for control group, 1414 (511–
4052) cysts for TCBZ treated group, and 259 (38–1953) cysts
for OFZ treated group (Table 1). All remaining cysts in the OFZ
pigs were evidently degenerated. Furthermore, the numbers of
cysts were statistically signiﬁcantly smaller in OFZ group
compared with the TCBZ and control groups (P < 0.01).
TCBZ had very little effect against the parasitic cysts. Cysts
from animals in the TCBZ group looked apparently normal after
Figure 2. Histological section of cysts from a pig treated with OFZ (H&E
stain).
It showed moderate diffuse lymphocytic myositis and dystrophic calciﬁ-
cation (A). Presence of lymphocytes, ﬁbroblasts, connective tissue, tissue
mineralization with basophilic granules (B).
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moderate degree of inﬂammation composed of eosinophils,
macrophages, lymphocytes, plasmocytes, and ﬁbroblasts with
connective tissue in the surrounding parenchyma (Figure 1) in
all samples from this group. On the other hand, OFZ killed
100% of cysts in treated pigs, and all animals in this group
showed only degenerated cysts. The inﬂammatory reaction
around cysts from the OFZ group was severe, and also
demonstrated areas of dystrophic calciﬁcation (Figure 2). No
inﬂammatory reaction was observed in pericystic tissue samples
from pigs in the control group.
4. Discussion
T. solium cysticercosis remains a public health issue in many
developing countries, and therefore, the evaluation of new
alternative drugs for its control is urgently required. A very large
variety of antiparasitic drugs have been tested against cysti-
cercus so far [10]. Although almost all these anthelmintic drugs
are active against adult stages of cestodes, nematodes and
trematodes, only a few drugs that have a positive effect
against its larval stage [11,18].
TCBZ, a benzimidazole drug, has a potent effect against
adult and larval stages of some tissue helminths such as Fasciola
and Paragonimus [14]. Likewise, studies in vitro have been
shown effective activity in some nematodes and cestodes
[13,19]. On these bases, we evaluated the efﬁcacy of TCBZ
against porcine cysticercosis. TCBZ in a single dose of
30 mg/kg was not effective against cysticercosis in this group
of naturally infected pigs. On necropsy, there were no
apparent differences in cyst burden or cyst appearance
between pigs treated with TCBZ and pigs in the control group.
Microscopic evaluation of cysts from treated pigs with TCBZ
evidenced mild to moderate inﬂammatory reaction with presence
of different types of leukocytes. This indicates that cysts are not
found completely healthy, as observed at necropsy. This mild
inﬂammatory reaction, macroscopically imperceptible, suggests
that TCBZ has a slight effect against cysticerci raising the
question of whether higher or multiple doses could be efﬁca-
cious against cystic cestode larvae, as shown by Richter et al.
[19]. In that study, TCBZ had a positive activity againstEchinococcus multilocularis metacestodes in vitro, using a
20-d treatment regime. Increased doses or multiple doses
would still make TCBZ poorly practical for use in porcine
cysticercosis in ﬁeld conditions.
Several antihelminthic drugs (i.e. albendazole, ﬂubendazole,
fenbendazole, nitazoxanide, and praziquantel) have been tested
for the treatment of porcine cysticercosis. Albendazole was
evaluated using a single (50 mg/kg) and multiple doses (30 mg/
kg) in experimentally infected pigs, and it was effective using
multiple doses (3 consecutive days). However, some pigs treated
to single and multiple doses showed secondary effects as
anorexia, lethargy, prostration and death [11]. Nitazoxanide was
tested in naturally infected pigs using multiple doses (150 mg/
kg) by 7 consecutive days, and it was not effective against
cysts. Some pigs treated with nitazoxanide developed prostatic
hypertrophy and bladder distention [11]. In this experiment,
single doses of 30 mg/kg of either OFZ or TCBZ did not
produce any adverse effects in pigs. They were apparently
normal and did not show any signs of toxicity during and
after treatment.
Flubendazole and fenbendazole have show efﬁcacy against
porcine cysticercosis when used in multiple doses, 40 mg/kg for
10 d and 5 mg/kg for 7 d, respectively, without secondary ef-
fects. Furthermore, praziquantel has been shown to have efﬁcacy
against cysticerci using daily doses of 50 mg/kg for 15
consecutive days [11,20]. However, animal treatments using
multiple doses are impractical in ﬁeld conditions and not
suitable for mass chemotherapy campaigns in endemic zones.
In summary our ﬁndings do not support the use of TCBZ for
porcine cysticercosis, and conﬁrm the efﬁcacy of a single dose
of OFZ for muscle cysticercosis cysts.
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